Nobleza, Bb Girl .
HRN: 24-25-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/16/2023
12/22/2023
IV
39mg
OD
Potentially Septic Newborn
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes